Rivaroxaban Provides Adequate Protection for Cardioversion and AF Ablation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Outcomes Following Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
J Am Coll Cardiol 2013 Mar 13;[EPub Ahead of Print], JP Piccini, SR Stevens, Y Lokhnygina, et alFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.